The Future of excipient audits and COVID-19.
Iain Moore
President
EXCiPACT
A brief explanation of the EXCiPACT Certification Scheme for pharmaceutical excipients will be followed by an explanation of how the Scheme has been adapted without compromising quality as a result of the COVID-19 pandemic. The use of remote audits within the Scheme will be illustrated.
